News
Global Cannabis News & Analysis | Business of Cannabis
News · page 8
- Industry Trends
UK Medical Cannabis Market Growing ‘Faster Than Anyone Expected’
In 2025, the UK imported more than 30,000 kilograms of cannabis-based medicinal products (CBPMs), more than doubling for the second consecutive year, new data from Prohibition Partners shows.
- Prescribers & Clinics
Curaleaf International Launches CPD-Accredited Education Platform for UK Cannabis Prescribers
Curaleaf International has launched a free CPD-accredited online education platform for UK healthcare professionals to help close the training gap the country’s professional medical community continues to face.
- International Regulation
How Countries Legalise Cannabis Matters More Than Whether They Do, Lancet Review Finds
Thirteen years ago, Uruguay became the first country on the planet to officially legalise cannabis for recreational (adult-use) purposes.
- Hemp Industry
Is the US Hemp Ban Punishing the Wrong People?
This article was written for Business of Cannabis by Scott Mazza, Co-Founder of Vitality CBD and Certified Headies Uncertainty isn’t what hemp needs right now.
- US & Canada
DEA Selects Only Cannabis Opponents For Crucial June 29 Rescheduling Hearing
In the weeks since cannabis under a state medical licence was moved to Schedule III, US multi-state operators (MSOs) have wasted no time in capitalising on the historic reclassification.
- Public Markets
Listed – Part II: The Three Amigos
Trulieve’s uplisting to the NYSE, the first of its kind in US history, has undoubtedly caught the attention of every large North American cannabis operator.
- Medical Cannabis
France Sets July Deadline for Medical Cannabis Regulations as Withheld Study Shows Opioid Reductions
France’s health minister has confirmed to Agence France-Presse (AFP) that the delayed regulatory texts needed to push through its incoming generalised medical cannabis market will be published next month (July 2026).
- M&A Activity
Sanity Group Deepens Swiss Footprint With Astrasana Distribution Deal
Sanity Group has announced a new distribution partnership with Swiss cannabis operator Astrasana Holding AG, further expanding its footprint in the closely watched Swiss market.
- Pharmaceutical
Ananda Pharma Confirms Safety of MRX1 CBD Drug, as Clinical Pain Trials Approach
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
- Investment & Finance
Listed: Cannabis Finally Cracks America’s Major Exchanges
Cannabis stocks have, for the last five years or so, represented one of, if not the worst-performing, niche categories on any exchange.
- Patient Access
Ukraine Issues First Medical Cannabis Prescriptions, Two Years After Legalisation
First published on Cannabis Health On Thursday, 11 June, the first medical cannabis products were prescribed by neurologists at the Vinnytsia Regional Clinical Psychoneurological Hospital to Lyudmila Monastyrska, a patient with multiple sclerosis, and Yaroslav Yurchuk, a veteran who lost his leg a year ago while fighting in the Pokrovsk area.
- Press releases
Taima Growth Becomes Spain’s Fourth AEMPS-Licensed Medical Cannabis Cultivator
A Spanish startup has become one of only four companies authorised by Spain’s medicines regulator to cultivate medical cannabis, positioning itself to supply export markets in the UK and Germany from a pharmaceutical-grade indoor facility in the Ribera region of Burgos.
